223 related articles for article (PubMed ID: 19109398)
21. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
23. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
[TBL] [Abstract][Full Text] [Related]
24. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
27. Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Meyerhardt JA; Sloan JA; Sargent DJ; Goldberg RM; Pollak M; Morton RF; Ramanathan RK; Williamson SK; Findlay BP; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1402-10. PubMed ID: 15941948
[TBL] [Abstract][Full Text] [Related]
28. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
Yilmaz O; Eroglu A; Dag E; Karaoglanoglu N; Yilmaz A
Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
[TBL] [Abstract][Full Text] [Related]
31. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
Flood A; Mai V; Pfeiffer R; Kahle L; Remaley AT; Rosen CJ; Lanza E; Schatzkin A
Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
[TBL] [Abstract][Full Text] [Related]
32. Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
Lee SD; Chen LM; Kuo WW; Shu WT; Kuo WH; Huang EJ; Tsai CC; Li PC; Liu JY; Chen TH; Huang CY
Clin Chim Acta; 2006 May; 367(1-2):62-8. PubMed ID: 16406300
[TBL] [Abstract][Full Text] [Related]
33. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
34. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1.
Liu B; Cai LY; Lv HM; Xia L; Zhang YJ; Zhang HX; Guan YM
Gynecol Endocrinol; 2008 May; 24(5):285-8. PubMed ID: 18569034
[TBL] [Abstract][Full Text] [Related]
35. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
37. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
39. [Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].
Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamura K; Adachi M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):431-5. PubMed ID: 19295267
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of insulin-like growth factors (IGFs) and their binding proteins (IGFBPs), -1, -2, -3, in oral cancer.
Brady G; O'Regan E; Miller I; Ogungbowale A; Kapas S; Crean SJ
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):259-62. PubMed ID: 17113753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
